secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001104659-25-058874
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 2019 EIP amendment, increase share pool by 4M; directors elected
--------------------------------------------------------------------------------

- Proposal to amend 2019 EIP to remove evergreen provision and add 4,000,000 shares approved (8.04M for, 4.74M against, 14.9M broker non-votes).
- All eight director nominees elected: Joseph Oliveto, Stuart Duty, Seth Fischer, Lisa Giles, Joseph Papa, Andrew Saik, Michael Tomsicek, Robert Wills.
- Ratification of PwC as auditor passed with 28.1M for, 284k against, 159k abstentions.
- Non-binding advisory vote on executive compensation (9.2M for, 3.6M against) and triennial frequency (12.3M for 1-year) passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465925058874/0001104659-25-058874-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465925058874/tm2517690d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058874

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer